Synaptic Cell Adhesion Molecule 3 (SynCAM3) Deletion Promotes Recovery from Spinal Cord Injury by Limiting Glial Scar...

Area of Science:

• Neuroscience
• Cell Biology
• Regenerative Medicine

Background:

• Synaptic cell adhesion molecules (SynCAMs) are crucial for synapse formation, maintenance, and plasticity in the central nervous system (CNS).
• SynCAM3, located in the synaptic cleft, mediates connections between axons and astrocytes and is implicated in extracellular matrix (ECM) regulation.
• Astrocytic scarring (glial scarring) is a major impediment to CNS injury treatment, particularly following spinal cord injury (SCI).

Purpose of the Study:

• To investigate the role of SynCAM3 in astrocytic scar formation and ECM reconstitution after SCI.
• To determine the therapeutic potential of targeting SynCAM3 for improving functional recovery following SCI.

Main Methods:

• Spinal cord injury was induced in SynCAM3 knock-out (KO) and wild-type (WT) mice.
• Scar formation was assessed using single-cell RNA sequencing, qRT-PCR, and immunohistochemistry.
• Functional recovery was evaluated at four weeks post-injury.

Main Results:

• SynCAM3 KO mice exhibited significantly reduced glial scar formation compared to WT controls.
• The absence of SynCAM3 prevented the transformation of reactive astrocytes into scar-forming astrocytes.
• Improved ECM reconstitution and enhanced functional recovery were observed in SynCAM3 KO mice post-SCI.

Conclusions:

• SynCAM3 plays a critical role in the development of astrocytic scars following SCI.
• Selective removal of SynCAM3 mitigates scar formation and promotes functional recovery by modulating ECM reconstitution.
• SynCAM3 represents a promising novel therapeutic target for SCI treatment.